McGill University Health Center

Québec H4A 3J1

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Cystic Fibrosis, HER2 Positive Breast Cancer, Metastatic Urothelial Cancer

Studies at this site

• Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2) — Running, not enrolling
• A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes) — Completed
• MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients — Stopped early